295J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic 
Diseases: A Systematic Review
Saad Majeed Al-Tamimi*

Consultant Internist and Cardiologist, College of Dentistry, Al-Farahidi University, Baghdad, Iraq.
*Correspondence to: Saad Majeed Al-Tamimi (E-mail: saad65altamimy@yahoo.com)
(Submitted: 19 May 2022 – Revised version received: 22 June 2022 – Accepted: 07 July 2022 – Published Online: 26 October 2022)

Abstract
Background: HRVB (heart rate variability biofeedback) is a non-pharmacological method for chronic diseases evaluation.
Methods: Adults chronic sufferers, HRVB as the primary therapy with or without controlled circumstances, and psycho - physiological 
results as regression analysis were all included in a systematic search.
Results: There were 21 publications in overall. HRVB was found to be feasible in chronic patients with no adverse reactions, according to 
the findings. Significant favourable impacts on hypertension and cardiovascular prognostic, inflammation condition, asthma issues, 
depression and anxiety, sleeping disruptions, cognitive function, and pain were reported in diverse patient characteristics that could be 
linked to enhanced quality of life. Increases in treatment practice were accompanied by increases in heart rate variability, implying that 
HRVB may have a regulatory influence on autonomic function.
Conclusions: HRVB has the potential to help individuals with chronic conditions. More research is needed to reinforce these findings as well 
as identify the most efficient strategy.
Keywords: Biofeedback, psychology, heart rate, chronic disease

ISSN 2413-0516

Introduction
No communicable chronic conditions, such as cardiovascular 
diseases, malignancy, chronic lung disease, obesity, and mental 
health problems, had been accountable for about 70% of all 
mortality globally in 2016, according to the World Health 
Organization. Their worldwide incidence is rising, and the 
resulting socially and economically implications are becoming 
more severe.1

As a result, a fundamental priority for transforming 
healthcare and lowering health-care expenditures is the effi-
ciency and profitability of diseases control. Chronic disorders 
are often caused by disturbances in the autonomic nervous 
systems (ANS) balancing, which result in sympathetic sensory 
overload and a shortage of vasodilatation.2

This dysautonomia can be viewed as a result of disease, 
but it can also be viewed as a key potential cause in the onset 
and progression of chronic diseases. Physiological changes 
such as stress hormone production and secretion (e.g., cor-
tisol, norepinephrine), sleeping disturbances, pro-inflamma-
tory cytokine production (e.g., IL-6), hypertensions, or 
immunological malfunction can all lead to health decline and 
the formation of comorbidity.3

Furthermore, a modelling depending on various epide-
miological research found a relationship between reduced 
vagus nerve function and the aetio-pathogenesis of cardiovas-
cular disorders, cancer, and Alzheimer’s disease. Emphasis is 
being placed on therapies that could boost vagal activity and 
re-establish independent balancing in this context.4

Heart rate variability (HRV) is an indicator of health that 
is used to estimate parasympathetic performance and is evalu-
ated at resting. Low HRV is a predictor of cardiovascular 
illness and death risks, while elevated HRV represents the 
ability of the heart system to respond to internal and extrinsic 
alterations (e.g., anxiety, activity). Short-term autonomic 
modulation by the sympathetic nervous system (SNS) and the 
vagus nerve of the parasympathetic nervous system (PNS) 
causes cardiac variability.5

Each of those interconnected systems govern heart rate 
(HR) by increasing or shrinking it in response to physiological 
processes underlying in short-term HRV management, 
including baroreflex control and respiratory sinus arrhythmia 
(RSA). The first enhances HR once BP drops and reduces HR 
whenever BP rises; the latter enhances HR during intake and 
reduces HR during expiration.6

Physiological elements (e.g., hormones, inflammatory 
condition), neuropsychiatric elements (e.g., feelings, anxiety, 
cognitively regulations), and ecological or health behaviours 
all have a role in the long-term regulatory frameworks of HRV 
(e.g., physical exercises, tobacco, alcohol).7

HRV is defined by time fluctuations among each heart-
beat and is connected to the electrocardiogram’s RR interval 
(ECG). ECG or pulse wave measurements are used to deter-
mine HRV levels in both the time and frequency domains.8

The root mean squared of consecutive RR interval dis-
parities shows largely parasympathetic activity in the tem-
poral domain, while the standard deviations of 
normal-to-normal RR intervals (SDNN) indicates both sym-
pathetic and parasympathetic variations on HR. Short-term 
HRV assessment is mostly focused on the HRV power spec-
trum, which is separated into high frequency (HF; 0.15–0.4 
Hz) and low frequency (LF; 0.04–0.15 Hz) regions that tend to 
correspond with various physiological systems in the fre-
quency response.9

The HF-band represents respiratory impacts on HR mod-
ulation (RSA), which are caused by parasympathetic cardio 
vagal output, which causes rapid variations in HR. Aside from 
that, the LF-band correlates to bar reflex activities, which 
would be a virtuous cycle between sensory receptors and the 
brainstem that regulates blood pressure through both sympa-
thetic and parasympathetic output, resulting in significantly 
slower fluctuations in HR.10

LF-band, in particular, must be regarded as a representa-
tion of the baroreflex activity generated by both sympathetic 
and parasympathetic HR frequency modulation, rather than 
as the sole representation of sympathetic stimulation. The 

mailto:saad65altamimy@yahoo.com


296 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

intricacy of the physiological systems included in autonomic 
cardiovascular responses such as RSA and baroreflex activities 
should therefore be taken into account when interpreting the 
HRV power spectral density.11

HRV is controlled by the brainstem, cortical, and sub - 
cortical regions, and mental function may be altered by HRV 
due to neuronal interactions between the central autonomic 
networks and heart activities. According to current studies, 
the amygdala, insula, and anterior cingulate are all implicated 
in emotion regulation, implying that emotion and HRV are 
linked.12

Because vagal outflow prevails during rest due to substan-
tial cardio modulator impacts, the authors proposed a neu-
rovisceral implementation strategy in which vagal activities 
promote reciprocal heart-brain connection, implying that 
HRV may affect cerebral activities.13

Following that, according to McCraty and coworkers’ 
psychophysiological theory, a particular cardiac rhythm pat-
tern emerges once HR synchronises with other oscillatory 
components including RSA and baroreflex at a particular res-
onant frequencies equivalent to 6 breaths/min. Sine wave 
oscillations of respiration, HR, and BP represent synchronisa-
tion of these oscillatory processes and indicate a “coherence 
condition.” HRV is considerably boosted under these situa-
tions, according to the authors, due to increased vagal activa-
tion, which could have a good impact on brain activities and, 
in particular, emotional control. These heart-brain connec-
tions caused by vagal afferents and afferents indicate that vagal 
nerve stimulation has a role in the pathophysiology of chronic 
disorders and that vagal-activating therapies may be 
problematic.14

HRVB (heart rate variability biofeedback) is a non-phar-
macological method that improves emotional self-regulation 
and autonomic cardiac modulation by boosting HRV and 
recovering cardiac vagal function.15

Once breathing is around 6 breaths per minute, the baro-
reflex and the breath synchronise, resulting in a unique HRV 
signal sequence. This cardiac synchronization condition arises 
at a resonant frequencies of about 0.1 Hz, resulting in large 
amplitudes in HRV sine wave oscillations and a noticeable 
peak in the HRV power spectrum’s LF-band. Various 
researches have looked into the impacts of HRVB on different 
psychophysiological complaints associated with chronic dis-
eases since the late 1990s, and Lehrer has recommended a 
standardised technique of practice. HRVB has been shown to 
have good effects on stress in a meta-analysis, while a system-
atic review found that HRVB may have advantages for athletic 
performance.16

The goal of this systematic review was to see if HRVB may 
be an efficient and realistic non-pharmacological strategy for 
managing chronic illness sufferers. As a result, we conducted a 
review of all research involving elderly patients that looked at 
the impacts of HRVB training on psychophysiological results 
connected to chronic disorders.

Method

Search Strategy
Publications from the bibliographic resources PubMed/Med-
line, Springer Link, and ScienceDirect/Elsevier, that were sub-
mitted between 2010 and 2020, were reviewed.

Eligibility Criteria
All publications that matched the relevant particular needs of 
the established PICOS criteria relating to demographic, inter-
ventions, comparisons, outcomes, as well as research designs 
have been included in the systematic review: affected individ-
uals (over the age of 18) with chronic diseases; accounting the 
impacts of HRVB as a destined therapies for psychophysiolog-
ical diagnoses as regression model; assessing learning out-
comes of HRVB from minimally two sessions with guidelines 
for regulate frequencies respirations at roughly 6 breaths/min; 
and using a biofeedback equipment showing the HRV in 
actual time. We included all research strategies and compari-
sons methodologies with or without a control group to intro-
duce a comprehensive assessment of HRVB interventions for 
outcome measures. The study involved investigations that 
used HRVB lonely, HRVB in conjunction with standard treat-
ment, or HRVB in conjunction with another non-pharmaco-
logical interference, but only if the procedure would include a 
control group that received the same standard care or 
non-pharmacological interference, in order to assess the 
HRVB’s real benefit. Due to potential confounder’s issues in 
the interpretation of the data, we omitted investigations that 
coupled HRVB instruction with another non-pharmacolog-
ical treatment when the procedure did not provide a control 
group that permitted us to separate the HRVB different 
impacts.

Data Processing and Study Collection
To eliminate unintentional inclusion and exclusion, research 
screening was performed manually reviewing abstracts and 
then making revisions depending on the contents of each pub-
lication. Publications were initially categorised based on 
whether or not they fulfilled PICOS requirements; subse-
quently, publications that matched our eligibility requirements 
were documented, with information on procedure, measures, 
and outcomes. 

Results
Our screening approach turned up 626 papers (PubMed: 95; 
ScienceDirect: 23; Springer Link: 508), plus three more papers 
found through sourced citations. Numerous entries were 
deleted using the selection approach shown in Figure 1 due to 
duplication (repeated: 39) or because they were not relevant 
research articles. By implementing the previous reported qual-
ifying criteria in this sequence to the final 463 publications, 
434 were exempted: Adult people with chronic illnesses, 
excluding those medical settings such as substance abuse 
problems (due to the complicated matter concerning behav-
ioural problems) and pregnant women (and wasn’t a chronic 
condition); interventional research of HRVB exercise (2 or 
more discussions with particular respiration guidelines); and 
the use of a biofeedback instrument (heartbeat detector or 
ECG) with real-time HRV monitor. 

A collection of 21 investigations had been considered, 
encompassing 883 participants and sample sizes ranging from 
13 to 210, with the primary goal of analysing psychophysio-
logical results. There were 11 randomised controlled trials, 4 
unregulated investigations, and the rest were pilot, feasibility, 
or laboratory investigations that included a wait-list compar-
ison group, an apparently healthy comparison group, a 



297J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

conventional treatment control group, or another interven-
tional control subjects. Just trials examining the impacts of 
HRVB separately have been included in the randomized inves-
tigations. The only difference between the intervention and 
control groups in randomized research was the HRVB treat-
ment: HRVB vs. no treatment; HRVB vs. other treatments; 
HRVB + standard care vs. identical standard care; HRVB + 
alternative treatment vs. same other interference; HRVB + 
other interventions vs. same other intervention Table 1 sum-
marises them and categorises them by kind of chronic 
condition.

Feasibility in Chronic Patients

Adhesion

HRVB was evaluated in people with a diagnosis of chronic 
conditions and in a number of clinical settings. In a one-year 
longitudinal research, the maximal attrition incidence for 
HRVB respondents was observed to be about 25%, while 
assessed employment levels for HRVB everyday routine were 
over 70%.17 Time limits, transportation challenges, and other 
factors were mentioned in investigations as factors for 

Fig. 1 Flow chart for the literature search.



298 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
he

ar
t r

at
e 

va
ria

bi
lit

y 
 

bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Ca
rd

io
va

sc
ul

ar
 d

is
ea

se
s

Cl
im

ov
 e

t a
l. 

 
(2

01
4)

Co
ro

na
ry

 a
rt

er
y 

di
se

as
es

 
Ag

e 
ra

ng
ed

 fr
om

 
45

−
80

• R
an

do
m

iz
ed

 
co

nt
ro

l T
ria

l 
• H

ea
rt

 R
at

e 
 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

+
 

st
an

da
rd

 c
ar

e 
 

(n
 =

 1
3)

 
St

an
da

rd
 c

ar
e 

 
(n

 =
 1

1)

H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 D
EP

RE
SS

IO
N

 
SC

A
LE

; T
yp

e 
D

  
pe

rs
on

al
ity

; B
LO

O
D

 
PR

ES
SU

RE
; H

RV
 

In
te

rv
en

tio
ns

 
be

fo
re

 a
nd

 a
fte

r

10
 tr

ai
ni

ng
s 

 
(4

5−
60

 m
in

ut
es

) t
w

ic
e 

 
a 

w
ee

k 
+

 d
ai

ly

• 7
 in

di
vi

du
al

s 
w

ho
 

ha
ve

 s
lip

pe
d 

ou
t o

f 
th

e 
ne

ck
 im

pa
irm

en
t 

in
de

x 
(c

ar
ee

rs
 a

nd
 ti

m
e 

lim
ita

tio
ns

)

N
ot

 d
et

er
m

in
ed

• I
nc

re
as

e 
in

 th
e 

av
er

ag
e 

co
ns

is
te

nc
y 

ra
tin

g 
**

 
co

rr
el

at
ed

 w
ith

 S
D

N
N

I • H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 
D

EP
RE

SS
IO

N
 

SC
A

LE
; T

yp
e 

D
  

pe
rs

on
al

ity
; 

BL
O

O
D

  
PR

ES
SU

RE

N
ol

an
 e

t a
l. 

 
(2

01
0;

 2
01

2)
H

yp
er

te
ns

io
n 

Ag
e 

ra
ng

ed
 fr

om
 3

5 
to

 
64

 y
ea

rs

• R
an

do
m

iz
ed

 
co

nt
ro

l T
ria

l 
• H

EA
RT

 R
AT

E 
VA

R-
IA

BI
LI

TY
 B

IO
FE

ED
-

BA
CK

 (n
 =

 3
5)

 
• A

ut
og

en
ic

 re
lie

f  
(n

 =
 3

0)

BL
O

O
D

 P
RE

SS
U

RE
; 

ba
ro

re
fle

x 
se

ns
iti

v-
ity

; h
ig

h-
se

ns
iti

vi
ty

 
C-

re
ac

tiv
e 

pr
ot

ei
n;

 
IL

6;
 H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

O
ve

r t
he

 c
ou

rs
e 

of
 e

ig
ht

 
w

ee
ks

, t
he

re
 w

ill
 b

e 
si

x 
60

-m
in

ut
e 

tr
ai

ni
ng

 
se

ss
io

ns
 a

nd
 a

 2
0-

m
in

ut
e 

da
ily

 a
st

hm
a 

co
nt

ro
l t

es
t.

N
ot

 d
et

er
m

in
ed

• D
ay

tim
e 

BL
O

O
D

 P
RE

S-
SU

RE
**

 a
nd

 2
4 

h 
sy

st
ol

ic
 

BL
O

O
D

 P
RE

SS
U

RE
*,

 a
nd

 
pu

ls
e 

pr
es

su
re

*

• I
nc

re
as

e 
of

 H
F 

po
w

er
**

 
an

d 
IN

TE
RB

EA
T 

IN
TE

R-
VA

L*
* 

du
rin

g 
co

gn
iti

ve
 

ta
sk

 
• C

ha
ng

es
 in

 H
F 

po
w

er
 

ar
e 

ne
ga

tiv
el

y 
re

la
te

d 
to

 
in

cr
ea

se
s 

in
 h

ig
h-

 
se

ns
iti

vi
ty

 C
-r

ea
ct

iv
e 

 
pr

ot
ei

ns
. *

, r
es

po
ns

iv
e-

ne
ss

 to
 b

ar
or

efl
ex

es
 *

, 
an

d 
IN

TE
RB

EA
T 

 
IN

TE
RV

A
L*

• S
en

si
tiv

e 
to

 
th

e 
ba

ro
re

fle
x 

• C
ha

ng
es

 in
 

IN
TE

RL
EU

-
KI

N
-6

 h
ad

 n
o 

eff
ec

t o
n 

H
RV

 
pa

ra
m

et
er

s 
or

 b
ar

or
efl

ex
 

re
sp

on
si

ve
ne

ss
.

Pa
tr

on
 e

t a
l. 

 
(2

01
3)

Fo
llo

w
in

g 
he

ar
t 

su
rg

er
y,

 th
e 

pa
tie

nt
s’ 

ag
es

 ra
ng

ed
 fr

om
 5

2 
to

 6
9.

• R
an

do
m

iz
ed

  
co

nt
ro

l t
ria

l 
• H

EA
RT

 R
AT

E 
 

VA
RI

A
BI

LI
TY

  
BI

O
FE

ED
BA

CK
 +

 
st

re
ss

  
m

an
ag

em
en

ts
  

(n
 =

 1
3)

 
• S

tr
es

s 
 

m
an

ag
em

en
ts

  
(n

 =
 1

3)

SP
IE

LB
ER

G
ER

 S
TA

TE
 

A
N

XI
ET

Y 
IN

VE
N

-
TO

RY
; C

EN
TE

R 
FO

R 
EP

ID
EM

IO
LO

G
IC

A
L 

ST
U

D
IE

S-
D

EP
RE

S-
SI

O
N

 S
CA

LE
; H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

O
ve

r t
he

 c
ou

rs
e 

of
 tw

o 
w

ee
ks

, t
he

re
 w

ill
 b

e 
fiv

e 
45

-m
in

ut
e 

tr
ai

ni
ng

 
se

ss
io

ns
 a

nd
 a

 1
5-

m
in

ut
e 

da
ily

 a
st

hm
a 

co
nt

ro
l 

as
se

ss
m

en
t.

N
ot

 d
et

er
m

in
ed

• D
ep

re
ss

io
n 

(C
EN

TE
R 

FO
R 

EP
ID

EM
IO

LO
G

IC
A

L 
ST

U
D

-
IE

S-
D

EP
RE

SS
IO

N
 S

CA
LE

*)

• O
ve

ra
ll 

po
w

er
 is

  
in

cr
ea

si
ng

 *
*;

 
• C

ha
ng

es
 in

 H
RV

 w
er

e 
fo

un
d 

to
 b

e 
in

ve
rs

el
y 

re
la

te
d 

to
 c

ha
ng

es
 in

 
de

pr
es

si
on

*

• S
PI

EL
BE

RG
ER

 
ST

AT
E 

A
N

XI
ET

Y 
IN

VE
N

TO
RY

(C
on

tin
ue

d)



299J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Yu
 e

t a
l. 

 
(2

01
8)

Co
ro

na
ry

 a
rt

er
y 

di
se

as
e 

Ag
e 

ra
ng

e 
35

−
70

 y
ea

rs

• R
an

do
m

iz
ed

 
co

nt
ro

l t
ria

l 
• H

EA
RT

 R
AT

E 
VA

R-
IA

BI
LI

TY
 B

IO
FE

ED
-

BA
CK

 +
 s

ta
nd

ar
d 

ca
re

 (n
 =

 1
05

) 
• S

ta
nd

ar
d 

ca
re

  
(n

 =
 1

05
)

BE
CK

 D
EP

RE
SS

IO
N

 
IN

VE
N

TO
RY

; C
H

IN
ES

E 
H

O
ST

IL
IT

Y 
IN

VE
N

-
TO

RY
-S

H
O

RT
 F

O
RM

; 
H

RV
; c

ar
di

ov
as

cu
la

r 
pr

og
no

si
s 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

• F
ol

lo
w

-u
p 

af
te

r a
 

ye
ar

Si
x 

w
ee

kl
y 

tr
ai

ni
ng

 
se

ss
io

ns
• D

ro
po

ut
 ra

te
 o

f 
26

.4
7%

 in
 th

e 
H

EA
RT

 
RA

TE
 V

A
RI

A
BI

LI
TY

 B
IO

-
FE

ED
BA

CK
 g

ro
up

 a
nd

 
34

.4
4%

 in
 th

e 
co

nt
ro

l 
gr

ou
p

• D
ep

re
ss

io
n 

(B
EC

K 
D

EP
RE

SS
IO

N
 IN

VE
N

TO
RY

 
to

ta
l s

co
re

**
; c

og
ni

tiv
e 

de
pr

es
si

on
 s

ub
sc

al
e*

*)
; 

• H
os

til
ity

**
 (C

H
IN

ES
E 

H
O

S-
TI

LI
TY

 IN
VE

N
TO

RY
-S

H
O

RT
 

FO
RM

); 
• A

t t
he

 fo
llo

w
-u

p,
 th

e 
re

su
lts

 re
m

ai
ne

d 
th

e 
sa

m
e;

 
• R

ea
dm

is
si

on
s 

ar
e 

re
du

ce
d.

 
* 

an
d 

at
 fo

llo
w

-u
p,

 e
m

er
-

ge
nt

 v
in

so
m

ni
a 

in
te

ns
ity

 
in

de
xt

s 
**

• R
es

pi
ra

to
ry

 ra
te

 w
as

 
de

cr
ea

se
d 

**
; 

• A
t t

he
 fo

llo
w

-u
p,

 th
e 

ris
e 

in
 L

F 
po

w
er

**
 w

as
 

su
st

ai
ne

d

• A
t t

he
  

fo
llo

w
-u

p,
 th

er
e 

w
as

 n
o 

di
ffe

r-
en

ce
 b

et
w

ee
n 

th
e 

gr
ou

ps
 in

 
te

rm
s 

of
 re

du
c-

in
g 

al
l-c

au
se

 
re

ad
m

is
si

on
s 

an
d 

al
l-c

au
se

 
am

bu
la

to
ry

 
ca

re
.

Ob
es

ity

M
ey

er
 e

t a
l. 

(2
01

8)

In
di

vi
du

al
s 

w
ith

 a
 

BM
I o

f 3
0 

or
 h

ig
he

r 
ar

e 
co

ns
id

er
ed

 
ob

es
e.

 T
he

 p
ar

tic
i-

pa
nt

s 
ra

ng
ed

 in
 a

ge
 

fro
m

 1
8 

to
 4

5 
ye

ar
s 

ol
d.

• P
ilo

t s
tu

dy
 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

0)
 

• W
ai

t-
lis

t c
on

tr
ol

  
(n

 =
 1

0)

PE
RC

EI
VE

D
 S

TR
ES

S 
SC

A
LE

; P
AT

IE
N

T 
H

EA
LT

H
 Q

U
ES

TI
O

N
-

N
A

IR
E-

D
EP

RE
SS

IO
N

 
A

N
D

 A
N

XI
ET

Y;
 

SH
O

RT
 F

O
RM

 
G

EN
ER

A
L 

H
EA

LT
H

 
SU

RV
EY

; S
EL

F-
EF

FI
-

CA
CY

; H
RV

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r
• 3

-m
on

th
s 

fo
llo

w
-u

p

6 
tr

ai
ni

ng
s 

w
ee

kl
y

• E
ig

ht
 p

eo
pl

e 
dr

op
pe

d 
ou

t o
f t

he
 in

te
rv

en
tio

n.

• D
ep

re
ss

io
n 

(P
AT

IE
N

T 
H

EA
LT

H
 Q

U
ES

TI
O

N
-

N
A

IR
E-

D
EP

RE
SS

IO
N

 A
N

D
 

A
N

XI
ET

Y*
); 

• S
tr

es
s 

(P
ER

CE
IV

ED
  

ST
RE

SS
 S

CA
LE

*)
; 

• S
el

f-
effi

ca
cy

 (S
EL

F-
 

EF
FI

CA
CY

 s
um

 s
co

re
*)

; 
• Q

ua
lit

y 
of

 li
fe

 (B
od

ily
 

to
ta

l r
an

ks
* 

an
d 

m
en

ta
l 

to
ta

l g
oa

ls
 s

co
re

d*
* 

w
er

e 
pr

es
er

ve
d 

at
 fo

llo
w

-u
p 

 
on

 S
H

O
RT

 F
O

RM
  

G
EN

ER
A

L 
H

EA
LT

H
  

SU
RV

EY
) 

• P
oo

le
d 

re
su

lts

• S
D

N
N

**
 p

er
fo

rm
an

ce
 

im
pr

ov
em

en
t, 

to
ta

l 
po

w
er

 *
*;

 
• T

he
 re

du
ct

io
n 

in
  

re
sp

ira
to

ry
 ra

te
* 

w
as

  
su

st
ai

ne
d 

at
 th

e 
 

fo
llo

w
-u

p.

N
ot

 d
et

er
-

m
in

ed (C
on

tin
ue

d)



300 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

As
th

m
a

Le
hr

er
 e

t a
l. 

(2
01

8)

As
th

m
a 

Th
e 

pa
rt

ic
i-

pa
nt

s 
ra

ng
ed

 in
 a

ge
 

fro
m

 2
7 

to
 4

7 
ye

ar
s 

ol
d.

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L 
• H

EA
RT

 R
AT

E 
VA

RI
A

BI
LI

TY
 B

IO
-

FE
ED

BA
CK

 g
ro

up
 

(n
 =

 3
1)

 
EL

EC
TR

O
EN

CE
PH

A
-

LO
G

RA
M

 B
IO

FE
ED

-
BA

CK
 +

 s
oo

th
in

g 
m

us
ic

 +
 a

 g
ro

up
 o

f 
pe

op
le

 e
xh

al
in

g 
at

 
a 

ra
te

 o
f 1

5 
br

ea
th

s 
pe

r m
in

ut
e 

(n
 =

 3
3)

M
ET

AC
H

O
LI

N
E 

CH
A

LL
EN

G
E 

TE
ST

; 
A

ST
H

M
A

 C
O

N
TR

O
L 

TE
ST

; A
ST

H
M

A
 

Q
U

A
LI

TY
 O

F 
LI

FE
; 

sp
iro

m
et

ry
 a

nd
  

im
pu

ls
iv

e 
os

ci
l-

lo
m

et
ry

; e
ve

ry
da

y 
co

m
pl

ai
nt

s 
an

d 
m

ax
im

um
 o

ut
flo

w
s; 

ex
pe

lle
d 

ni
tr

ic
 o

xi
de

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

Sh
or

t p
ro

to
co

l (
n 

=
 2

0)
: 6

 
H

EA
RT

 R
AT

E 
VA

RI
A

BI
LI

TY
 

BI
O

FE
ED

BA
CK

 tr
ai

ni
ng

s 
ov

er
 1

0 
w

ee
ks

 +
 2

0-
m

in
-

ut
es

 p
er

 d
ay

 p
ra

st
hm

a 
co

nt
ro

l t
es

tic
e 

Lo
ng

 
pr

ot
oc

ol
 (n

 =
 1

1)
: 1

0 
H

EA
RT

 R
AT

E 
VA

RI
A

BI
LI

TY
 

BI
O

FE
ED

BA
CK

 te
n 

w
ee

ks
 

of
 p

ra
ct

ic
e 

Pl
us

 a
 d

ai
ly

 
pr

as
th

m
a 

co
nt

ro
l t

es
t o

f 
tw

en
ty

 m
in

ut
es

• 1
9 

pe
rc

en
t o

f t
he

 to
ta

l 
of

 p
at

ie
nt

s 
le

av
e 

ou
t.

• A
st

hm
a 

co
m

pl
ai

nt
s 

(A
ST

H
M

A
 C

O
N

TR
O

L 
TE

ST
**

; 
A

ST
H

M
A

 Q
U

A
LI

TY
 O

F 
LI

FE
**

); 
• S

en
si

tiv
ity

 o
f a

irw
ay

s 
 

(M
ET

AC
H

O
LI

N
E 

CH
A

L-
LE

N
G

E 
TE

ST
**

); 
• F

un
ct

io
ni

ng
 o

f t
he

 lu
ng

s 
(m

ax
im

um
 v

el
oc

ity
 *

); 
• D

ys
fu

nc
tio

n 
of

 th
e 

ai
r-

w
ay

s 
w

ith
 in

te
rv

al
s 

of
 p

oo
r 

as
th

m
a 

sy
m

pt
om

s*
 (n

itr
o-

ge
n 

di
ox

id
e 

re
le

as
ed

 *
)

N
ot

 d
et

er
m

in
ed

• J
us

t a
fte

r t
he

r-
ap

y,
 th

er
e 

w
as

 
no

 d
iff

er
en

ce
 

in
 A

ST
H

M
A

 
CO

N
TR

O
L 

TE
ST

, 
A

ST
H

M
A

 Q
U

A
L-

IT
Y 

O
F 

LI
FE

, 
M

ET
AC

H
O

LI
N

E 
CH

A
LL

EN
G

E 
TE

ST
, o

r m
ax

i-
m

al
 c

irc
ul

at
io

n 
ac

ro
ss

 g
ro

up
-

in
gs

; 
• T

he
re

 is
 n

o 
di

ffe
re

nc
e 

be
-

tw
ee

n 
a 

qu
ic

k 
an

d 
a 

le
ng

th
y 

tr
ea

tm
en

t.

Ch
ro

ni
c b

ra
in

 in
ju

ry

Ki
m

 e
t a

l. 
(2

01
3)

Ch
ro

ni
c 

br
ai

n 
in

ju
ry

 
Ag

e 
=

 2
3−

63

• P
ilo

t s
tu

dy
 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

3)
 

• N
o 

co
nt

ro
l g

ro
up

IN
TE

G
RA

TE
D

 V
IS

U
A

L 
A

N
D

 A
U

D
IT

O
RY

; 
CO

N
TI

N
U

O
U

S 
PE

RF
O

RM
A

N
CE

 T
ES

T;
 

BE
H

AV
IO

R 
RA

TI
N

G
 

IN
VE

N
TO

RY
 O

F 
EX

EC
U

TI
VE

 F
U

N
C-

TI
O

N
-A

D
U

LT
; H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

W
ee

kl
y 

tr
ea

tm
en

t o
f t

en
 

se
ss

io
ns

 a
nd

 a
 re

si
de

nt
ia

l 
as

th
m

a 
co

nt
ro

l a
ss

es
s-

m
en

t f
ro

m
 s

es
si

on
 fo

ur
.

• N
ot

 d
et

er
m

in
ed

• N
ot

 d
et

er
m

in
ed

• I
m

pr
ov

em
en

t i
n 

th
e 

co
ns

is
te

nc
y 

pr
op

or
tio

n*
 

an
d 

th
e 

LF
/H

F 
pr

op
or

-
tio

n 
**

; 
• T

he
 c

oh
er

en
t r

at
io

s*
 

an
d 

th
e 

LF
/H

F 
ra

tio
 

w
er

e 
co

nn
ec

te
d 

w
ith

 
em

ot
io

na
l s

ta
bi

lit
y 

an
d 

ve
rb

al
 m

em
or

ie
s 

(B
EH

AV
-

IO
R 

RA
TI

N
G

 IN
VE

N
TO

RY
 

O
F 

EX
EC

U
TI

VE
 F

U
N

C-
TI

O
N

-A
D

U
LT

) *
*;

 
• A

tt
en

tio
n 

(IN
TE

G
RA

TE
D

 
VI

SU
A

L 
A

N
D

 A
U

D
IT

O
RY

 +
 

CO
N

TI
N

U
O

U
S 

PE
RF

O
R-

M
A

N
CE

 T
ES

T)
 c

or
re

la
te

d 
w

ith
 L

F/
H

F*
*

• N
ot

 d
et

er
-

m
in

ed (C
on

tin
ue

d)



301J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Ch
an

g 
et

 a
l. 

(2
02

0)
Ac

ut
e 

is
ch

em
ic

 
st

ro
ke

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L 
H

EA
RT

 R
AT

E 
 

VA
RI

A
BI

LI
TY

 
BI

O
FE

ED
BA

CK
 +

 
st

an
da

rd
 c

ar
e 

 
(n

 =
 1

9)
 

• S
ta

nd
ar

d 
Ca

re
  

(n
 =

 1
9)

M
IN

I-M
EN

TA
L 

ST
A

-
TU

S 
EX

AM
IN

AT
IO

N
; 

H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 D
EP

RE
SS

IO
N

 
SC

A
LE

; H
RV

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r
• O

ne
 a

nd
 th

re
e 

m
on

th
s

4 
da

ys
 o

f t
ra

in
in

g 
pr

oc
es

s 
+

 2
0 

m
in

ut
es

 o
f d

ai
ly

 
as

th
m

a 
m

an
ag

em
en

t 
te

st
in

g 
ov

er
 th

re
e 

m
on

th
s.

• T
hr

ee
 p

eo
pl

e 
ha

d 
to

 
dr

op
 o

ut
.

• O
n-

th
e-

be
ds

id
e 

tr
ai

ni
ng

 s
es

si
on

s 
ar

e 
m

on
ito

re
d.

• A
nx

ie
ty

 a
nd

 d
ep

re
ss

io
n 

(H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 
D

EP
RE

SS
IO

N
 S

CA
LE

*)
 a

t  
1 

an
d 

3 
m

on
th

s 
• C

og
ni

tiv
e 

fu
nc

tio
ns

 
(M

IN
I-M

EN
TA

L 
ST

AT
U

S 
EX

AM
IN

AT
IO

N
**

) a
t 1

 a
nd

 
3 

m
on

th
s

• D
ec

re
as

e 
of

 h
ea

rt
 ra

te
* 

at
 1

 a
nd

 3
 m

on
th

s; 
• I

nc
re

as
e 

of
 S

D
N

N
*,

 
RM

SS
D

*,
 L

F*
 a

nd
 

to
ta

l p
ow

er
* 

at
 1

 a
nd

 3
 

m
on

th
s

N
ot

 d
et

er
-

m
in

ed

Ch
ro

ni
c p

ai
n

D
ob

bi
n 

et
 a

l. 
(2

01
3)

Re
fra

st
hm

a 
co

nt
ro

l 
te

st
or

y 
irr

ita
bl

e 
 

bo
w

el
 s

yn
dr

om
e 

Ag
e 

=
 1

8−
60

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 3

1)
 

• H
yp

no
th

er
ap

y 
 

(n
 =

 3
0)

• R
A

N
D

O
M

IZ
ED

  
CO

N
TR

O
L 

TR
IA

L
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r 
• F

ol
lo

w
-u

p 
af

te
r 

th
re

e 
m

on
th

s

IR
RI

TA
BL

E 
BO

W
EL

 
SY

N
D

RO
M

E 
SY

M
PT

O
M

 
SE

VE
RI

TY
 S

CO
RE

S;
 

H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 
D

EP
RE

SS
IO

N
 S

CA
LE

 

O
ve

r t
he

 c
ou

rs
e 

of
 

tw
el

ve
 w

ee
ks

, t
he

re
 

w
ill

 b
e 

th
re

e 
60

-m
in

ut
e 

tr
ai

ni
ng

 c
ou

rs
es

 a
nd

 a
 

20
-m

in
ut

e 
da

ily
 a

st
hm

a 
co

nt
ro

l a
ss

es
sm

en
t.

• 1
5 

dr
op

ou
ts

  
(7

 in
 H

EA
RT

 R
AT

E 
 

VA
RI

A
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 g

ro
up

)

• S
ym

pt
om

s 
(IB

SS
SS

*)
 a

t 
po

st
-in

te
rv

en
tio

n;
 

• A
nx

ie
ty

 a
nd

 d
ep

re
ss

io
n 

(H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 
D

EP
RE

SS
IO

N
 S

CA
LE

*)
 

• A
t t

he
 fo

llo
w

-u
p,

 th
e 

re
su

lts
 re

m
ai

ne
d 

th
e 

sa
m

e.

N
ot

 d
et

er
m

in
ed

• T
he

re
 h

as
 

be
en

 n
o 

di
st

in
ct

io
n 

on
 

th
e 

H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 
D

EP
RE

SS
IO

N
 

SC
A

LE
 a

fte
r t

he
 

tr
ea

tm
en

t.

W
ee

ks
 e

t a
l. 

(2
01

5)

≥
3 

m
on

th
s 

of
  

ch
ro

ni
c 

di
sc

om
fo

rt
 

(fi
br

om
ya

lg
ia

,  
he

ad
ac

he
s, 

 
ne

ur
op

at
hy

, e
tc

.) 
 

45
 to

 6
8 

ye
ar

s 
ol

d

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L 
H

EA
RT

 R
AT

E 
VA

RI
-

A
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

0)
 

• F
ee

db
ac

k 
fa

de
  

(n
 =

 1
0)

: f
ee

db
ac

k 
le

ve
ls

 w
er

e 
sl

ow
ly

 
re

du
ce

d 
fro

m
  

90
%

 to
 0

%
.

10
-c

m
 v

is
ua

l a
na

lo
g 

sc
al

e 
(V

A
S)

; P
A

IN
 

D
IS

A
BI

LI
TY

 Q
U

ES
-

TI
O

N
N

A
IR

E;
 1

1-
IT

EM
 

TA
M

PA
 S

CA
LE

 O
F 

KI
N

ES
IO

PH
O

BI
A

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r 

• F
ol

lo
w

-u
p 

af
te

r 
th

re
e 

m
on

th
s

O
ve

r t
he

 c
ou

rs
e 

of
 th

re
e 

w
ee

ks
, t

he
re

 w
ill

 b
e 

ni
ne

 
tr

ai
ni

ng
 s

es
si

on
s.

• 6
 d

ro
pp

ed
 o

ut
 o

f t
he

 
in

te
rv

en
tio

ns
; 

• A
t t

he
 fo

llo
w

-u
p 

 
ex

am
in

at
io

n,
 th

re
e 

w
er

e 
m

is
si

ng
.

• N
ot

 d
et

er
m

in
ed

• N
ot

 d
et

er
m

in
ed

Pa
in

 in
te

ns
ity

 
on

 V
A

S,
 T

SK
 1

1,
 

PA
IN

 D
IS

A
BI

LI
-

TY
 Q

U
ES

TI
O

N
-

N
A

IR
E (C

on
tin

ue
d)



302 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Ca
nc

er

G
re

en
be

rg
  

et
 a

l. 
(2

01
5)

N
on

-s
m

al
l c

el
l l

un
g 

ca
nc

er
 (N

SC
LC

) i
s 

a 
ty

pe
 o

f l
un

g 
ca

nc
er

.  
Th

e 
pa

rt
ic

ip
an

ts
’ 

ag
es

 ra
ng

ed
 fr

om
  

46
 to

 7
1.

• I
nt

er
be

at
 in

te
r-

va
lli

ty
 fe

as
ib

ili
ty

 
an

al
ys

is
 

• H
EA

RT
 R

AT
E 

VA
RI

A
BI

LI
TY

 B
IO

-
FE

ED
BA

CK
 g

ro
up

 
(n

 =
 1

6)
 

• T
he

re
 is

 n
o 

co
nt

ro
l 

gr
ou

p.

H
O

SP
IT

A
L 

A
N

XI
ET

Y 
A

N
D

 D
EP

RE
SS

IO
N

 
SC

A
LE

; P
AT

IE
N

T 
H

EA
LT

H
 Q

U
ES

TI
O

N
-

N
A

IR
E;

 F
A

ST
H

M
A

 
CO

N
TR

O
L 

TE
ST

L;
 D

is
-

tr
es

s T
he

rm
om

et
er

 
an

d 
Pr

ob
le

m
 A

re
as

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r

Si
x 

ex
er

ci
se

 s
es

si
on

s 
 

(3
0–

45
 m

in
ut

es
) 

th
ro

ug
ho

ut
 c

he
m

ot
he

r-
ap

y 
Pl

us
 a

 d
ai

ly
 a

st
hm

a 
m

an
ag

em
en

t a
ss

es
s-

m
en

t o
f 2

0 
m

in
ut

es

• T
he

re
 w

er
e 

ei
gh

t 
ca

se
s 

in
 to

ta
l; 

• 1
 h

ad
 fi

ni
sh

ed
 th

e 
pr

og
ra

m
; 

• H
EA

RT
 R

AT
E 

VA
RI

A
BI

L-
IT

Y 
BI

O
FE

ED
BA

CK
 d

on
e 

du
rin

g 
ch

em
ot

he
ra

py
; 

• T
hr

ou
gh

ou
t t

ra
in

in
g 

se
ss

io
ns

, t
he

 p
ot

en
tia

l 
to

 re
du

ce
 re

sp
ira

to
ry

 
ra

te
, h

ea
rt

 ra
te

, a
nd

 
an

xi
et

y

• T
he

re
 a

re
 n

o 
st

at
is

tic
al

 
an

al
ys

is
 a

va
ila

bl
e.

N
ot

 d
et

er
m

in
ed

N
ot

 d
et

er
-

m
in

ed

De
pr

es
si

on

Ca
ld

w
el

l e
t a

l. 
(2

01
8)

M
aj

or
 d

ep
re

ss
iv

e 
di

so
rd

er
 (M

D
D

) i
s 

a 
ty

pe
 o

f d
ep

re
ss

io
n 

th
at

 1
8 

to
 2

5 
ye

ar
s 

ol
d

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L 
• H

EA
RT

 R
AT

E 
VA

RI
A

BI
LI

TY
 

BI
O

FE
ED

BA
CK

 +
 

ps
yc

ho
th

er
ap

y 
 

(n
 =

 1
0)

 
• P

sy
ch

ot
he

ra
py

  
(n

 =
 1

0)
 

• N
on

-d
ep

re
ss

ed
 

co
nt

ro
l g

ro
up

  
(n

 =
 1

1)

BE
CK

 D
EP

RE
SS

IO
N

 
IN

VE
N

TO
RY

; H
RV

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r

Fi
ve

 s
es

si
on

s 
+

  
15

–2
0 

m
in

ut
es

 o
f a

st
h-

m
a 

sy
m

pt
om

s 
at

 h
om

e.
 

O
ve

r t
he

 c
ou

rs
e 

 
of

 s
ix

 w
ee

ks
, 4

–5
  

in
st

an
ce

s 
ea

ch
 w

ee
k

N
ot

 d
et

er
m

in
ed

• D
ep

re
ss

io
n 

(B
D

III
**

)
• S

D
N

N
**

N
ot

 d
et

er
-

m
in

ed

H
ar

to
gs

 e
t a

l. 
(2

01
7)

M
aj

or
 d

ep
re

ss
iv

e 
di

so
rd

er
 (M

D
D

) T
he

 
pa

rt
ic

ip
an

ts
 ra

ng
ed

 
in

 a
ge

 fr
om

 2
3 

to
 6

2

• E
xp

er
im

en
ta

l 
st

ud
y 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

0)
 

• T
he

re
 is

 n
o 

co
nt

ro
l 

gr
ou

p

BE
CK

 D
EP

RE
SS

IO
N

 
IN

VE
N

TO
RY

; P
O

SI
TI

VE
 

O
U

TC
O

M
E 

LI
ST

; H
RV

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r

Ei
gh

t w
ee

kl
y 

tr
ai

ni
ng

 
se

ss
io

ns
 (4

5–
60

 m
in

ut
es

) 
+

 a
 d

ai
ly

 p
ra

st
hm

a 
co

nt
ro

l t
es

t o
f t

w
en

ty
 

m
in

ut
es

• T
hr

ee
 fa

ilu
re

s 
du

e 
to

 a
 

la
ck

 o
f m

ot
ili

ze
d 

vi
su

al
 

an
d 

au
ra

l i
nt

eg
ra

tio
n;

 
• S

ev
en

 p
eo

pl
e 

fin
is

he
d 

th
e 

en
tir

e 
pr

og
ra

m
; 

• O
ne

 d
ep

re
ss

iv
e 

w
or

se
ni

ng

Fi
ve

 p
ar

tic
ip

an
ts

 h
av

e 
ha

d 
cl

in
ic

al
 b

en
efi

ts
: 

• D
ep

re
ss

io
n 

(B
D

I) 
• E

le
m

en
ts

 o
f r

es
ili

en
cy

 
(P

O
SI

TI
VE

 O
U

TC
O

M
E 

LI
ST

 
Au

to
no

m
y 

ra
tin

gs
); 

(H
AM

D
 

to
ta

l s
co

re
**

)

• D
ur

in
g 

th
e 

pr
og

ra
m

, 
th

e 
de

gr
ee

 o
f c

on
si

st
-

en
cy

 o
f fi

ve
 p

ar
tic

ip
an

ts
 

im
pr

ov
ed

.
• T

he
 a

ve
ra

ge
 H

R 
ha

s 
de

cr
ea

se
d 

*

N
ot

 d
et

er
-

m
in

ed (C
on

tin
ue

d)



303J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Li
n 

et
 a

l. 
(2

01
9)

M
aj

or
 d

ep
re

ss
iv

e 
di

so
rd

er
 A

ge
 ra

ng
ed

 
fro

m
 2

0 
to

 7
5 

ye
ar

s.

• C
as

e-
co

nt
ro

l 
st

ud
y 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 2

4)
; 

• C
on

tr
ol

 o
f t

he
 

w
ai

tin
g 

lis
t (

n 
=

 2
4)

BE
CK

 A
N

XI
ET

Y 
IN

VE
N

TO
RY

; B
EC

K 
D

EP
RE

SS
IO

N
 IN

VE
N

-
TO

RY
; P

IT
TS

BU
RG

H
 

SL
EE

P 
Q

U
A

LI
TY

 
IN

D
EX

; P
RE

-S
LE

EP
 

A
RO

U
SA

L 
SC

A
LE

; 
H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

• F
ol

lo
w

-u
p 

af
te

r o
ne

 
m

on
th

Si
x 

w
ee

kl
y 

tr
ai

ni
ng

 s
es

-
si

on
s 

(6
0 

m
in

ut
es

) P
lu

s 
da

ily
 p

ra
st

hm
a 

co
nt

ro
l 

te
st

ic
e 

of
 1

0 
m

in
ut

es

• T
he

re
 w

er
e 

fiv
e 

 
w

ith
dr

aw
al

s.

• D
ep

re
ss

io
n 

(B
EC

K 
D

EP
RE

SS
IO

N
 IN

VE
N

TO
RY

 
to

ta
l s

co
re

**
, c

og
ni

tiv
e 

de
pr

es
si

on
*,

 s
om

at
ic

 
de

pr
es

si
on

*)
; 

• A
nx

ie
ty

 (B
EC

K 
A

N
XI

ET
Y 

IN
VE

N
TO

RY
 to

ta
l s

co
re

**
); 

• S
le

ep
 (P

RE
-S

LE
EP

 A
RO

U
S-

A
L 

SC
A

LE
 to

ta
l s

co
re

*,
 

PI
TT

SB
U

RG
H

 S
LE

EP
 Q

U
A

LI
-

TY
 IN

D
EX

 to
ta

l s
co

re
**

, a
nd

 
co

gn
iti

ve
 a

ro
us

al
 o

f P
RE

-
SL

EE
P 

A
RO

U
SA

L 
SC

A
LE

**
) 

• A
t t

he
 fo

llo
w

-u
p,

 th
e 

re
su

lts
 re

m
ai

ne
d 

th
e 

sa
m

e.

• R
es

pi
ra

to
ry

 ra
te

  
de

cr
ea

se
s 

**
; 

• S
D

N
N

**
, L

F 
po

w
er

*,
 L

F/
H

F*
, a

nd
 o

ve
ra

ll 
po

w
er

* 
al

l i
nc

re
as

ed
**

; 
At

 th
e 

fo
llo

w
-u

p,
 th

e 
re

su
lts

 re
m

ai
ne

d 
th

e 
sa

m
e.

• N
o 

di
ffe

re
nc

e 
be

tw
ee

n 
gr

ou
ps

 fo
r 

PI
TT

SB
U

RG
H

 
SL

EE
P 

Q
U

A
LI

TY
 

IN
D

EX
 a

nd
  

PR
E-

SL
EE

P 
A

RO
U

SA
L 

SC
A

LE
 to

ta
l 

sc
or

es

Ch
ro

ni
c s

tr
es

s

D
e 

Br
ui

n 
et

 a
l. 

(2
01

6)

Ch
ro

ni
c 

st
re

ss
 e

va
lu

-
at

ed
 fr

om
 P

ER
CE

IV
ED

 
ST

RE
SS

 S
CA

LE
 s

co
re

 
Ag

e 
ra

ng
ed

 fr
om

 1
8 

to
 4

0

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L
• H

EA
RT

 R
AT

E 
VA

R-
IA

BI
LI

TY
 B

IO
FE

ED
-

BA
CK

 (n
 =

 2
5)

 
• M

ed
ita

tio
n 

fo
r 

aw
ar

en
es

s 
(n

 =
 2

7)
 

• P
hy

si
ca

l a
ct

iv
ity

  
(n

 =
 2

3)

AC
S;

 B
EH

AV
IO

R 
RA

TI
N

G
 IN

VE
N

TO
-

RY
 O

F 
EX

EC
U

TI
VE

 
FU

N
C

TI
O

N
-A

D
U

LT
; 

FF
M

Q
SF

; S
EL

FC
O

M
-

PA
SS

IO
N

 S
CA

LE
-

SH
O

RT
 F

O
RM

; 
PE

N
N

 S
TA

TE
 W

O
RR

Y 
Q

U
ES

TI
O

N
N

A
IR

E 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r
• F

ol
lo

w
 u

p 
af

te
r  

6 
m

on
th

s.

O
ve

r t
he

 c
ou

rs
e 

of
 fi

ve
 

w
ee

ks
: 1

st
 w

ee
k:

 1
0 

m
in

-
ut

es
 p

er
 d

ay
 2

nd
 w

ee
k 

=
 1

5 
m

in
ut

es
 p

er
 d

ay
 

W
ee

ks
 3

–5
 =

 2
0 

m
in

ut
es

 
pe

r d
ay

• T
he

re
 w

er
e 

19
 

w
ith

dr
aw

al
s 

in
 th

e 
H

EA
RT

 R
AT

E 
VA

RI
A

-
BI

LI
TY

 B
IO

FE
ED

BA
CK

 
ca

te
go

ry
, i

nc
lu

di
ng

 o
ne

 
in

 th
e 

H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

BA
CK

 
co

ho
rt

 (o
cc

up
at

io
ns

 
an

d 
tim

e 
co

ns
tr

ai
nt

); 
• P

ar
tic

ip
an

ts
 w

ith
 

an
 a

tt
en

da
nc

e 
ra

te
 

of
 m

or
e 

th
an

 7
0%

 
sh

ow
ed

 g
re

at
er

 g
ai

ns
.

• A
tt

en
tio

n 
co

nt
ro

l*
 (A

CS
); 

• E
xe

cu
tiv

e 
fu

nc
tio

n-
in

g*
 (B

EH
AV

IO
R 

RA
TI

N
G

 
IN

VE
N

TO
RY

 O
F 

EX
EC

U
TI

VE
 

FU
N

C
TI

O
N

-A
D

U
LT

); 
• M

in
df

ul
 a

w
ar

en
es

s*
 (F

IV
E 

FA
CE

T 
M

IN
D

FU
LN

ES
S 

Q
U

ES
TI

O
N

N
A

IR
E-

SH
O

RT
 

FO
RM

); 
• S

el
f-

co
m

pa
ss

io
n*

 
(S

EL
FC

O
M

PA
SS

IO
N

 S
CA

LE
-

SH
O

RT
 F

O
RM

); 
• W

or
ry

in
g*

 (P
EN

N
 S

TA
TE

 
W

O
RR

Y 
Q

U
ES

TI
O

N
N

A
IR

E)
 

• W
he

n 
co

m
pa

re
d 

to
 it

s 
pe

er
s, 

at
te

nt
io

n 
co

nt
ro

l 
an

d 
ex

ec
ut

iv
e 

fu
nc

tio
ni

ng
 

ha
d 

sm
al

l i
m

pa
ct

 v
al

ue
s 

at
 

fo
llo

w
-u

p.

N
ot

 d
et

er
m

in
ed

At
 th

e 
po

st
- 

in
te

rv
en

tio
n 

an
d 

fo
llo

w
-u

p,
 

th
er

e 
w

as
 n

o 
su

bs
ta

nt
ia

l 
di

st
in

ct
io

n.

(C
on

tin
ue

d)



304 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

H
al

lm
an

 e
t a

l. 
(2

01
1)

St
re

ss
 re

la
te

d 
ch

ro
ni

c 
ne

ck
 s

ho
ul

de
r p

ai
n 

Ag
e 

ra
ng

ed
 fr

om
 2

5 
to

 5
0 

ye
ar

s

• P
ilo

t s
tu

dy
 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

2)
 

• T
he

 c
on

tr
ol

 g
ro

up
 

(n
 =

 1
2)

 p
ar

tic
ip

at
-

ed
 in

 s
es

si
on

s 
1 

an
d 

10
 w

ith
ou

t r
ec

ei
v-

in
g 

an
y 

gu
id

an
ce

 in
 

be
tw

ee
n.

Bo
rg

 C
R1

0;
 S

TR
ES

S 
M

ED
IC

IN
E 

SY
M

PT
O

M
 

SC
A

LE
; H

O
SP

IT
A

L 
A

N
XI

ET
Y 

A
N

D
 

D
EP

RE
SS

IO
N

 S
CA

LE
; 

SH
O

RT
 F

O
RM

 
G

EN
ER

A
L 

H
EA

LT
H

 
SU

RV
EY

; N
EC

K 
D

IS
A

-
BI

LI
TY

 IN
D

EX
; H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

Te
n 

tr
ai

ni
ng

 s
es

si
on

s 
ev

er
y 

w
ee

k.
N

ot
 d

et
er

m
in

ed

• Q
ua

lit
y 

of
 li

fe
 (o

n 
th

e 
SH

O
RT

 F
O

RM
 G

EN
ER

A
L 

H
EA

LT
H

 S
U

RV
EY

, b
od

ily
 

pa
in

*,
 s

oc
ia

l f
un

ct
io

n*
, a

nd
 

vi
ta

lit
y*

*)

• L
F 

po
w

er
**

 in
cr

ea
se

s; 
LF

 p
ow

er
*,

 p
N

N
50

*,
 a

nd
 

IN
TE

RB
EA

T 
IN

TE
RV

A
L 

* 
im

pr
ov

e 
th

ro
ug

ho
ut

 
st

re
ss

 re
co

ve
ry

.

• S
TR

ES
S 

M
ED

I-
CI

N
E 

SY
M

PT
O

M
 

SC
A

LE
, B

or
g 

CR
10

, a
nd

 
N

EC
K 

D
IS

A
-

BI
LI

TY
 IN

D
EX

, 
H

O
SP

IT
A

L 
A

N
XI

ET
Y 

A
N

D
 

D
EP

RE
SS

IO
N

 
SC

A
LE

Va
n 

de
r Z

w
an

 
et

 a
l. 

(2
01

5)

Ch
ro

ni
c 

st
re

ss
 w

as
 

as
se

ss
ed

 u
si

ng
 

SC
A

LE
 O

F 
PE

RC
EI

VE
D

 
ST

RE
SS

 T
he

 p
ar

tic
i-

pa
nt

s 
ra

ng
ed

 in
 a

ge
 

fro
m

 1
8 

to
 4

0 
ye

ar
s 

ol
d.

• R
A

N
D

O
M

IZ
ED

 
CO

N
TR

O
L 

TR
IA

L 
• H

EA
RT

 R
AT

E 
VA

R-
IA

BI
LI

TY
 B

IO
FE

ED
-

BA
CK

 (n
 =

 2
6)

 
Ph

ys
ic

al
 e

xe
rc

is
e 

 
(n

 =
 2

3)
 

M
ed

ita
tio

n 
fo

r 
aw

ar
en

es
s 

(n
 =

 2
7)

D
EP

RE
SS

IO
N

 
A

N
XI

ET
Y 

ST
RE

SS
 

SC
A

LE
S;

 P
IT

TS
BU

RG
H

 
SL

EE
P 

Q
U

A
LI

TY
 

IN
D

EX
; S

CA
LE

S 
O

F 
PS

YC
H

O
LO

G
IC

A
L 

W
EL

L-
BE

IN
G

 
• I

nt
er

ve
nt

io
ns

 b
ef

or
e 

an
d 

af
te

r
• F

ol
lo

w
 u

p 
af

te
r s

ix
 

m
on

th
s

O
ve

r t
he

 c
ou

rs
e 

of
 fi

ve
 

w
ee

ks
: 1

st
 w

ee
k:

 1
0 

m
in

-
ut

es
 p

er
 d

ay
 2

nd
 w

ee
k 

=
 1

5 
m

in
ut

es
 p

er
 d

ay
 

W
ee

ks
 3

–5
 =

 2
0 

m
in

ut
es

 
pe

r d
ay

• N
in

e 
po

st
-t

es
t a

nd
/

or
 fo

llo
w

-u
p 

ex
am

in
a-

tio
ns

 w
er

e 
m

is
si

ng
; 

• I
nd

iv
id

ua
ls

 w
ith

 a
 p

ar
-

tic
ip

at
io

n 
ra

te
 o

f m
or

e 
th

an
 7

0%
 s

ho
w

ed
 

gr
ea

te
r g

ai
ns

.

• S
tr

es
s*

*,
 a

nx
ie

ty
**

, a
nd

 
de

pr
es

si
on

**
 (D

EP
RE

SS
IO

N
 

A
N

XI
ET

Y 
ST

RE
SS

 S
CA

LE
S)

; 
• W

el
l-b

ei
ng

**
 (S

CA
LE

S 
O

F 
PS

YC
H

O
LO

G
IC

A
L 

W
EL

L-
 

BE
IN

G
);

• S
le

ep
 q

ua
lit

y*
 (P

IT
TS

-
BU

RG
H

 S
LE

EP
 Q

U
A

LI
TY

 
IN

D
EX

); 
• A

t t
he

 fo
llo

w
-u

p,
 th

e 
re

su
lts

 re
m

ai
ne

d 
th

e 
sa

m
e.

N
ot

 d
et

er
m

in
ed

• A
t p

os
t-

in
te

r-
ve

nt
io

n 
an

d 
fo

llo
w

-u
p,

 th
er

e 
w

er
e 

no
 d

iff
er

-
en

ce
s 

be
tw

ee
n 

gr
ou

ps
.

Ps
yc

hi
at

ric
 d

is
or

de
rs

Je
st

er
 e

t a
l. 

(2
01

8)

In
di

ca
tio

ns
 o

f 
ps

yc
hi

at
ric

 d
is

ea
se

s 
(d

ep
re

ss
iv

e,
 a

nx
i-

et
y,

 a
nd

 b
ip

os
iti

ve
 

ou
tc

om
e 

lis
ta

r 
di

so
rd

er
s)

 T
he

 a
ge

s 
of

 th
e 

pa
rt

ic
ip

an
ts

 
ra

ng
ed

 b
et

w
ee

n 
63

 
to

 9
6 

ye
ar

s 
ol

d.

• E
xp

er
im

en
ta

l 
st

ud
y 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 2

0)
 

• N
o 

co
nt

ro
l g

ro
up

SP
IE

LB
ER

G
ER

 S
TA

TE
 

A
N

XI
ET

Y 
IN

VE
N

TO
RY

; 
BE

CK
 D

EP
RE

SS
IO

N
 

IN
VE

N
TO

RY
; T

RA
IL

 
M

A
KI

N
G

 T
ES

T 
PA

RT
 A

 
A

N
D

 B
 

In
te

rv
en

tio
ns

 b
ef

or
e 

an
d 

af
te

r

O
ve

r t
he

 c
ou

rs
e 

of
 th

re
e 

w
ee

ks
, t

he
re

 w
ill

 b
e 

si
x 

30
-m

in
ut

e 
tr

ai
ni

ng
 s

es
-

si
on

s 
pl

us
 a

 h
om

e 
as

th
-

m
a 

co
nt

ro
l a

ss
es

sm
en

t 
tw

o 
tim

es
 p

er
 w

ee
k.

• P
ar

tic
ip

an
ts

 h
ig

h-
lig

ht
ed

 th
e 

im
pa

ct
 o

f 
H

EA
RT

 R
AT

E 
VA

RI
A

-
BI

LI
TY

 B
IO

FE
ED

BA
CK

 
on

 s
tr

es
s 

or
 c

on
ce

rn
 

(6
7%

), 
de

pr
es

si
on

 o
r 

so
rr

ow
 (5

6%
), 

an
d 

st
re

ss
 (4

4%
); 

or
 n

o 
be

ne
fit

s 
of

 H
EA

RT
 R

AT
E 

VA
RI

A
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 o

n 
te

ns
io

n 
(5

0%
); 

• A
nx

ie
ty

 s
ym

pt
om

s 
ar

e 
sl

ig
ht

ly
 w

or
se

ne
d 

(c
om

pe
tit

iv
e 

na
tu

re
 o

f 
BF

 s
of

tw
ar

e)
 o

ne
 p

ar
-

tic
ip

an
t h

as
 c

on
fir

m
ed

 
th

is.

• D
ep

re
ss

io
n*

* 
(B

D
III

); 
• S

ta
te

 a
nx

ie
ty

**
 a

nd
  

tr
ai

t a
nx

ie
ty

**
 a

re
 tw

o 
ty

pe
s 

of
 a

nx
ie

ty
 (S

PI
EL

-
BE

RG
ER

 S
TA

TE
 A

N
XI

ET
Y 

IN
VE

N
TO

RY
);

• A
tt

en
tio

n 
sk

ill
s 

(T
M

T-
A

**
)

N
ot

 d
et

er
m

in
ed

N
ot

 d
et

er
-

m
in

ed (C
on

tin
ue

d)



305J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

Ta
bl

e 
1.

 T
he

 b
as

el
in

e 
ch

ar
ac

te
ris

tic
s o

f e
ac

h 
in

cl
ud

ed
 st

ud
y—

Co
nt

in
ue

d

St
ud

y
Sa

m
pl

e
St

ud
y 

de
si

gn
in

g
De

pe
nd

en
t f

as
th

m
a 

co
nt

ro
l t

es
to

rs
 a

nd
 

fu
lfi

lm
en

t t
im

e

He
ar

t r
at

e 
va

ria
bi

lit
y 

bi
of

ee
db

ac
k 

in
te

rv
en

tio
n

Vi
ab

ili
ty

Si
gn

ifi
ca

nt
 ch

an
ge

s i
n 

 
He

ar
t R

at
e 

Va
ria

bi
lit

y 
 

Bi
of

ee
db

ac
k 

co
ho

rt

He
ar

t r
at

e 
va

ria
bi

lit
y 

in
ec

k 
di

sa
bi

lit
y 

in
de

xe
s

No
n-

si
gn

ifi
ca

nt
 

ou
tc

om
es

Sc
hu

m
an

 e
t a

l. 
(2

01
8)

Po
st

-T
ra

um
at

ic
 S

tr
es

s 
D

is
or

de
r (

PT
SD

). 
 T

he
 

pa
rt

ic
ip

an
ts

 ra
ng

ed
 

in
 a

ge
 b

et
w

ee
n 

26
 

un
til

 5
0 

ye
ar

s 
ol

d.

• P
ilo

t S
tu

dy
 

• H
EA

RT
 R

AT
E 

 
VA

RI
A

BI
LI

TY
 B

IO
-

FE
ED

BA
CK

  
(n

 =
 6

) 
Co

nt
ro

lli
ng

 th
e 

w
ai

tli
st

 w
ith

 
br

ea
th

in
g 

te
ch

-
ni

qu
es

 (n
 =

 6
)

PT
SD

 C
H

EC
KL

IS
T 

FO
R 

TH
E 

D
SM

5;
 H

RV
 

• I
nt

er
ve

nt
io

ns
 b

ef
or

e 
an

d 
af

te
r

• F
ol

lo
w

 u
p 

ra
ng

ed
 

fro
m

 fo
ur

 to
 1

6 
w

ee
ks

.

O
ve

r t
he

 c
ou

rs
e 

of
  

4 
w

ee
ks

, O
ne

 s
es

si
on

 +
  

10
–1

5 
m

in
ut

es
 tw

ic
e 

da
ily

 p
ra

st
hm

a 
co

nt
ro

l 
te

st
ic

e

• T
he

 p
ro

ce
du

re
 w

as
 

pe
rf

or
m

ed
 b

y 
te

n 
pe

op
le

;
• D

ai
ly

 p
ra

st
hm

a 
m

on
ito

rin
g 

te
st

ic
e 

pa
rt

ic
ip

at
io

n 
ra

te
 o

f 
>

70
%

; 
• S

ym
pt

om
s 

in
cl

ud
e 

a 
de

cr
ea

se
 in

 in
di

vi
du

al
s’ 

irr
ita

bi
lit

y,
 a

nx
ie

ty
, a

nd
 

sl
ee

p 
di

st
ur

ba
nc

es
.

• P
TS

D
-s

pe
ci

fic
 s

ym
pt

om
s 

(P
TS

D
 C

H
EC

KL
IS

T 
FO

R 
TH

E 
D

SM
5*

) m
ai

nt
ai

ne
d 

at
 

fo
llo

w
s-

up
 

• T
he

 re
su

lts
 h

av
e 

be
en

 
co

m
bi

ne
d.

• R
M

SS
D

* 
in

cr
ea

se
d 

at
 

th
e 

16
-w

ee
k 

fo
llo

w
-u

p
N

ot
 d

et
er

-
m

in
ed

Ta
n 

et
 a

l. 
 

(2
01

1)

Po
st

-T
ra

um
at

ic
 S

tr
es

s 
D

is
or

de
r (

PT
SD

). 
Th

e 
pa

rt
ic

ip
an

ts
 ra

ng
ed

 
in

 a
ge

 fr
om

 2
4 

to
 6

2 
ye

ar
s 

ol
d.

• P
ilo

t s
tu

dy
 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 +

 s
ta

nd
ar

d 
ca

re
 (n

 =
 1

0)
 

• S
ta

nd
ar

d 
ca

re
  

(n
 =

 1
0)

CL
IN

IC
IA

N
-A

D
M

IN
IS

-
TE

RE
D

 P
TS

D
 S

CA
LE

; 
PT

SD
 C

H
EC

K-
LI

ST
-S

PE
CI

FI
C 

In
te

rv
en

tio
ns

 b
ef

or
e 

an
d 

af
te

r

O
ve

r t
he

 c
ou

rs
e 

of
 8

 
w

ee
ks

, t
he

re
 w

ill
 b

e 
8 

tr
ai

ni
ng

 s
es

si
on

s 
(h

al
f a

n 
ho

ur
 e

ac
h)

 a
nd

 a
 2

0-
m

in
-

ut
e 

as
th

m
a 

co
nt

ro
l t

es
t 

tw
o 

tim
es

 p
er

 d
ay

.

• 1
 d

ro
po

ut
 (t

ra
ns

po
rt

 
pr

ob
le

m
); 

• P
ar

tic
ip

an
ts

 ra
te

d 
th

e 
H

EA
RT

 R
AT

E 
VA

RI
A

-
BI

LI
TY

 B
IO

FE
ED

BA
CK

 
in

te
rv

en
tio

n 
as

 a
n 

8/
10

 
fo

r s
at

is
fa

st
hm

a 
co

nt
ro

l 
an

d 
th

at
 th

ey
 h

ad
 a

 
pl

ea
sa

nt
 ti

m
e.

• P
TS

D
-s

pe
ci

fic
 s

ym
pt

om
s 

(C
LI

N
IC

IA
N

-A
D

M
IN

IS
TE

RE
D

 
PT

SD
 S

CA
LE

**
; P

TS
D

 
CH

EC
KL

IS
T-

SP
EC

IF
IC

*)

N
ot

 d
et

er
m

in
ed

• A
t t

he
 e

nd
 o

f 
th

e 
in

te
rv

en
-

tio
n,

 th
er

e 
w

as
 

no
 d

iff
er

en
ce

 
be

tw
ee

n 
th

e 
gr

ou
ps

.

Tr
ou

ss
el

ar
d 

 
et

 a
l. 

(2
01

6)

Re
m

itt
ed

 s
ch

iz
o-

ph
re

ni
a 

Ag
e 

ra
ng

ed
 

fro
m

 2
5 

to
 4

6 
ye

ar
s.

• P
ilo

t s
tu

dy
 

• H
EA

RT
 R

AT
E 

VA
R-

IA
BI

LI
TY

 B
IO

FE
ED

-
BA

CK
 (n

 =
 1

0)
 

• N
o 

co
nt

ro
l g

ro
up

SP
IE

LB
ER

G
ER

 S
TA

TE
 

A
N

XI
ET

Y 
IN

VE
N

TO
RY

; 
D

ER
O

G
AT

IS
 S

TR
ES

S 
PR

O
FI

LE
; P

O
SI

TI
VE

 
A

N
D

 N
EG

AT
IV

E 
SY

N
D

RO
M

E 
SC

A
LE

; 
W

A
RW

IC
K–

ED
IN

-
BU

RG
H

 M
EN

TA
L 

W
EL

L-
BE

IN
G

 S
CA

LE
; 

FR
EI

BU
RG

 M
IN

D
FU

L-
N

ES
S 

IN
VE

N
TO

RY
 

In
te

rv
en

tio
ns

 b
ef

or
e 

an
d 

af
te

r

W
ee

kl
y 

tr
ai

ni
ng

 s
es

si
on

s 
of

 8
–1

2 
ho

ur
s 

(o
ne

 h
ou

r)
 

pl
us

 d
ai

ly
 re

la
xa

tio
n 

te
ch

ni
qu

es
.

• N
o 

dr
op

ou
t; 

• M
os

t p
eo

pl
e 

w
an

t t
o 

re
m

ai
n 

af
te

r q
ui

tt
in

g;
 

• I
n 

in
di

vi
du

al
s 

w
ith

 a
 

hi
gh

 le
ve

l o
f c

om
-

pl
ai

nt
s, 

th
er

e 
ar

e 
m

or
e 

be
ne

fit
s.

• M
in

df
ul

ne
ss

* 
 

(F
RE

IB
U

RG
 M

IN
D

FU
LN

ES
S 

IN
VE

N
TO

RY
); 

• A
nx

ie
ty

 s
tr

es
so

rs
* 

an
d 

em
ot

io
na

l s
tr

es
so

r*
 

(D
ER

O
G

AT
IS

 S
TR

ES
S 

PR
O

FI
LE

)

N
ot

 d
et

er
m

in
ed

W
A

RW
IC

K–
 

ED
IN

BU
RG

H
 

M
EN

TA
L 

W
EL

L-
 

BE
IN

G
 S

CA
LE

, 
PO

SI
TI

VE
 A

N
D

 
N

EG
AT

IV
E 

SY
N

-
D

RO
M

E 
SC

A
LE

, 
SP

IE
LB

ER
G

ER
 

ST
AT

E 
A

N
XI

ET
Y 

IN
VE

N
TO

RY

*<
0.

05
; *

*≤
0.

01
; “

N
ot

 d
et

er
m

in
ed

” i
m

pl
ie

s 
th

at
 th

is
 d

at
a 

w
as

 n
ot

 n
ot

ed
 in

 th
e 

st
ud

y.



306 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

withdrawals,18–20 and medical defects.21 Because to significant 
dropout rates in lung cancer sufferers owing to disease-related 
health and lifestyle decline or mortality, one procedure was 
early discontinued.21

Satisfaction

Generally, participants were pleased with the stress reduction 
and positive feeling improvement they experienced while bio-
feedback, and the advantages lasted for a long time.17,20,22,23 
None of the respondents in any of the research looked at 
expressed displeasure. Participants with remitted schizo-
phrenia readily finished the intervention with no participation 
requirement, and the majority expressed an incentive to keep 
afterward due to claimed psychological advantages.23 There 
was a 67 percent acceptance rating for beneficial effects on 
anxiety or worry amongst elderly patients with psychiatric 
conditions, as well as 56 percent satisfaction for state of depres-
sion or sorrow and 50 percent satisfaction for stress.22

Adverse Effects

HRVB was found to have no major side effects, indicating that 
it is safe to use in patients with chronic conditions. Other 
minor side effects were noted, including such anxiety, due to 
the intrinsic pressure felt by sufferers to fulfil the biofeedback 
device’s predefined respiratory objectives.22 A familiarisation 
phase was adopted in a procedure to gradually eliminate the 
respiratory rating from a natural rhythm of ~14 breaths/min 
to a goal rate of ~6 breaths/minute to minimise any frustra-
tions linked to sluggish breath and hyperventilation.24

Efficacy in Terms of Psychophysiological Results

Cardiovascular Disorders and Hypertensive Disorders

HRVB was helpful in lowering 24-hour systolic blood pres-
sure (–2.1 0.9 mmHg, P = 0.03) and 24-hour pulse pressure 
(–1.40.6 mmHg, P = 0.02) following 8 weeks of regular 
practise, according to a randomised controlled trial (RCT) 
involving 65 participants (autogenic relaxation).25 A trial of 
24 patients with atrial fibrillation found no change in blood 
pressure.18 Since the participants were already on beta-blocker 
medications when the trial began, all initial systolic and dias-
tolic BP readings were within normal ranges through the 
latter example, which indicates a substantial restriction of the 
outcomes. As a consequence, HRVB appears to have a benefi-
cial effect on blood pressure in hypertensive individuals and 
cardiovascular prognosis in heart sufferers.

Inflammatory Condition

In a research of 65 hypertension individuals, a negative rela-
tionship between alterations in the inflammatory condition 
(evaluated by highly sensitive C-reactive proteins and inter-
leukin-6) and efferent vagal activity (evaluated by HF power, 
RR interval, and baroreflex activities) was discovered.26 The 
researchers hypothesized that increasing efferent vagal action 
would reduce pro-inflammatory mediators, implying that 
HRVB could have anti-inflammatory properties. 

Asthma Disorders

All asthma attacks and lung capacity increased in two Rand-
omized trials with 94 and 64 participants, respectively, and 

airway inflammation decreased. When compared to the con-
trol group, food and medicine intake was decreased after  
10 weeks of daily HRVB practise, indicating that HRVB has a 
lot of potential in the particular treatment of asthma attacks.27 
HRVB was more successful in lowering prescription usage 30 
and airways inflammations than electroencephalogram (EEG) 
biofeedback and standard treatment,27 It was also just as effi-
cient as active controls at alleviating asthma attacks,27 bron-
chial permeability and lung capacity.27

Anxiety, Depression, and Psychological Response

HRVB was found to have substantial favourable impact in 12 
of the 15 research that looked at depression as a predictor var-
iables; similarly, HRVB was found to have significant positive 
impacts in 9 of the 12 studies that looked at stress and anxiety. 
In 12 investigations involving 326 different patient features 
who suffered from mental illness, depressed mood, tension, 
and anxiety were considerably reduced,28–30 persistent discom-
fort,31 chronic stress,32 psychiatric disorders22,23 and obesity.33 
Anxiety and despair levels were reduced over many weeks to a 
year after HRVB treatment.30–32

Other beneficial psychological consequences were assessed, 
including greater mindfulness practice, self-compassion, and 
well-being. In two investigations with a total of 151 patients suf-
fering from chronic stress19,32 and one research with ten partic-
ipants in remission from schizophrenia, there was a reduction 
in worry or anger.23

Disruptions in Sleep

Three of the four studies that looked at sleep problems found 
that HRVB improved sleeping patterns in individuals with 
severe depressed disorders,30 and anxiety symptoms (totalling 
162 participants). Increases in sleeping were linked to lower 
levels of depression30 and stress.32

Characteristics of Post-Traumatic Stress Disorder (PTSD)

In three investigations involving 60 patients, PTSD-specific 
indicators decreased considerably following 4–8 weeks of 
HRVB therapy. In a research with a small sample size of 20 
participants, HRVB was found to be no more efficient than the 
traditional therapy.20

Cognitive Performances

Massive gains in attention skills and executive functioning in 
individuals afflicted by chronic stress,19 executive function in 
individuals with mental signs, 38 have been implemented to 
enhance cognitive capacities. In addition, individuals who had 
an acute ischemic stroke improved their cognitive function 
significantly.23,24 Nevertheless, no improvement in cognitive 
abilities were identified in 13 individuals with persistent brain 
damage, which is likely owing to the kind of neurological 
problems.34

Pain

50 participants with irritable bowel syndrome and 24 individ-
uals with stress-related chronic neck-shoulder pain improved 
following HRVB exercise.35 Improvements were sustained 
three months following HRVB exercise, according to one 
research.31 A further research, nevertheless, contradicts these 



307J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

findings, finding no substantial pain decrease in patients with 
diverse chronic pain characteristics.36 There was no informa-
tion about the prescriptions and/or use of painkillers.

Lifestyle

Advancements in quality of life, particularly a rather more 
active lifestyle and a rise in both social and physical perfor-
mance, were found to be linked to a reduction in pain 50 and 
PTSD-related indicators.17

Discussion

Modifications in HRV may Mitigate the 
Relationship of Interventions
The HRVB benefits on HRV were documented in 11 of the 21 
investigations in the literature review. The lowered mean HR25 
and breathing percentage at rest30,33 all over meetings, as well 
as the enhanced cohesion proportion throughout sessions,18 
showed highest synchronisation between respiratory and car-
diovascular processes, recommend that individuals correctly 
performed HRVB activities and demonstrate the impacts of 
routine practice. HRV indicators that increased in time, such 
as SDNN,24,29,30,33 pNN31 or RMSSD,24 and in frequencies, such 
as overall power,24,30,33 suggested an improvement in cardiac 
autonomic regulation. 9 Numerous studies have found that 
higher HRV values are linked to better outcome measures. In 
patients with chronic brain damage, a higher consistency pro-
portion was linked to enhanced affective and psychological 
functioning.37 In cardiovascular events, greater HF power was 
linked to lower stress and anxiety levels, as well as lower 
inflammation condition in hypertensive individuals.26 As a 
consequence, the authors suggest that by boosting overall 
HRV and completely overwhelming cardiac vagus nerve 
activity, HRVB could have inhibitory action on autonomic 
function implicated in physiological control systems. The cen-
tral-autonomic combination of vagal afferents may help to 
improve psycho - physiological performance in a more cohe-
sive and effective process in this manner.38 Furthermore, by 
optimising and enabling interrelated biological processes,  
0.1 Hz oscillations as a resonant frequencies may play a prom-
inent part in physical and mental health.39 HRVB could be a 
potential strategy for managing a broad variety of ailments 
conditions and their effects by increasing vagal heart activity.40

Troublesome Explanation of HRV
The HF power reflects PNS arousal while spontaneous 
breathing at resting (about 10–15 breaths/min), while the LF 
power mostly indicates baroreflex action influenced by both 
SNS and PNS. Whereas an elevation in HF strength indicates 
an elevation in PNS arousal, a rise in LF power may result in a 
rise in baroreceptor regulation controlled by ANS control and 
cannot clearly differentiate synchronous from parasympa-
thetic involvement. The findings of HRV in the spectral 
domain in the research used in this study were characterized 
as the reinstitution of cardiac vagal regulation, expressed in 
either HF or LF regions. Furthermore, the effect of respiratory 
rate on HRV radio spectrum demonstrates that for a respira-
tory rate under 9 breaths/min, vagal activities may pass over 
into the LF-band.41-43 Latest discoveries reveal that parasympa-
thetic inhibition can remove HRV power in the LF-band in 

healthy persons beneath slow breathing conditions, showing 
the importance of cardiac vagal activity throughout a limited 
range of frequencies of 4–9 breaths/minute.44 In this respect, 
some studies propose increasing the frequencies limitation 
between the HF and LF bands from 0.15 Hz to 0.1 Hz to 
account for the particular effects of slow breathing on the HRV 
frequency distribution as well as the complicated interactions 
among PNS and SNS signalling heart-brain connections.39

Numerous technical features of HRV signal acquisition, 
including such monitoring length, instrument employed 
(ECG or pulse sensor), HRV variables evaluated, and respira-
tory circumstances, vary between procedures. Ventilation was 
not measured in any of the procedures, therefore not deter-
mined on breathing rate, tidal volume, or intake to exhalation 
ratios was supplied, although their recognised impacts on 
HRV.45 Respiratory variables should be observed to interpret 
the data more precisely because variations in rhythms of respi-
ration may alter the HRV power spectrum as a potential medi-
ator.43 Other variables that may play a role in HRV regulation, 
such as medicine and physically activities,46 must also be taken 
into account. As a consequence, studies relating to the increase 
of HRV indices must be regarded with caution, as they do not 
show a direct cause-and-effect connection among HRVB and 
ANS control.

HRVB Versus Other Interventions
The known methods implementations were also explored as 
component of this systematic review. HRVB was largely effec-
tive when opposed to normal care or waiting listing controlled 
trials47,29,30,33,35 but not when contrasted to active controls that 
included various non-pharmacological treatments.19,27,31,32 
Autogenic relaxing, progressive muscle relaxation, electroen-
cephalogram biofeedback,27 hypnotherapy, 50 mindfulness 
training, and physical activity19,32 have all been shown to 
improve psycho - physiological results. HRV indicators were 
not enhanced by any of the other non-pharmacological treat-
ments utilised as a controlled group, indicating HRVB’s dis-
tinct abilities on autonomic cardiac modulation (Table 1). 
Whenever HRVB is used in conjunction with regular care, the 
findings demonstrate that it can be used as an adjunctive 
therapy for clinical patients. Nevertheless, since of potential 
confounders, we eliminated some of the studies that show 
promising prospects for integrated non-pharmacological ther-
apies in chronic illness treatment, such as physically exercises, 
healthcare management,48 or relaxation techniques.49

Guidelines for HRVB Training Regimes
The majority of the regimens we looked at gave 4–12 moni-
tored workshops with ongoing home practise. Home practise 
was created to strengthen diaphragmatic breathing instruc-
tions and enhance HRV responsiveness, whereas monitored 
training were offered to ensure that HRVB activities were 
completed. The authors discovered a dose-response relation-
ship between HRVB practise and symptomatology decrease19,32 
implying the need of consistent practise and the presence of a 
practise barrier at which HRVB can deliver the desired results. 
We may estimate that optimum practise should comprise at 
least one monitored workshop accompanied by consistent 
home practise of at least 10 minutes daily for four weeks 
depending on the examined publications. This finding is con-
sistent with previously reported HRVB protocol guidelines, 
which suggest 5 monitored sessions with 20-minute daily 



308 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

practises.50 Patients may choose shorter practise hours if they 
are concerned about dropping out due to time constraints. 
HRVB practise, on the other hand, is likely to be helpful when 
tailored to the patient’s profiles and skills, with the option of 
providing more monitored sessions and extended procedures 
as needed.

Guidelines for HRVB Training Programs
The researchers of the examined procedures have offered a 
series of findings: To prevent minor side effects, provide a 
familiarisation phase of slow breathing activities at the start of 
the treatment (anxiety or breathlessness);47,24 practice the slow 
abdomen breathing exercises by introducing pursed-lips 
abdominal breathing with slightly delayed exhale;24 and, all 
through the session, gradually reduce the amount of time sub-
jected to optical biofeedback in order to develop full inde-
pendence in HRVB practise.36 Lehrer’s methodology includes 
a brief anti-hyperventilation warning (“In hopes of avoiding 
hyperventilation during the timed respiration activity, kindly 
eliminate exceedingly breathing techniques.”).50 Participants 
who are new to 0.1 Hz respiration must be given instructions 
to “breathe superficially and spontaneously.” Even though it 
has been demonstrated that an participant’s HR frequencies 
range makes it easier to enter cardiac coherence phase,51  
HRVB has often been established on roughly 6 breaths/min. In 
terms of the inhalation/exhalation proportion (i/e), a lower i/e 
ratio appears to result in enhanced relaxing, reducing stress, 
mindfulness, and good energy in participants 68, and a 1/2 
proportion could boost baroreflex responsiveness.52 Others’ 
findings, on the other hand, demonstrate that a 1/1 ratio is 
more beneficial than extended exhalation (40 percent intake 
and 60 percent expiration) in increasing HRV.53 As a result, 
more research is required to explain these various issues and 
to find the best beneficial breathing technique.

Future Studies Possibilities
Our findings are consistent with earlier studies that show 
HRVB has a favourable impact on clinical results and demon-
strate that HRVB is a viable and prospective treatment option 
for people with chronic conditions.40,54,55 The researchers con-
cluded that HRVB could help restore autonomic heart control 
and emotional self-control, as evidenced by the positive asso-
ciation between clinical results and HRV indicators.26,37,34,56 
Given the role of the autonomic nervous system in pathogen-
esis6 and the fact that HRV is a measure of cardiac morbidity, 
a potential regulating impact of HRVB on functional status 
provides attractive alternative therapy possibilities. Our 
research is hampered by the lack of risk-of-bias evaluation of 
the included research, despite the fact that it gives a qualitative 
summary of HRVB outcomes and methods. Given the diver-
sity of procedures employed in HRVB studies, subsequent 
papers should emphasise analysing risk of bias, evaluating the 

significance of every report’s results, and doing meta-analyses 
to get more firm conclusions on the possible impact of HRVB.

Further controlled trials are needed to much more pre-
cisely assess the efficacy of HRVB in comparison to standard 
treatment and effective control circumstances (e.g., relaxation, 
mindfulness meditation, physical exercise). As potential con-
founders, respiratory rhythm (incidence, peak flow, and inspi-
ration to exhalation ratio), physical activity, and medications 
should all be observed.46 As according respiratory rate and 
HRV signals collection, the various time and frequency 
parameters of HRV should be properly analysed.42 Investiga-
tors may be inspired by a beautiful study whose findings were 
released after the comprehensive study’s eligibility deadline.57 
It was carried out on depressed patients, and the procedure 
was based on a very thorough medication regimen that 
included a 5-week HRVB intervention during psychiatric 
inpatient recovery. The findings demonstrated an increase in 
HRV-LF amplitude and consistency ratios, as well as a reduc-
tion in depression scores and resting breathing rate, indicating 
that physicians have great potential. Different analysis tech-
niques to enhance the extracting included in HRV must be 
prepared and implemented in the future for a reliable estima-
tion of functional connectivity utilising HRV. Quantitative 
evaluations of HRVB’s impact on sympathetic cardiac control 
could possibly be more useful.58 Lastly, in future investiga-
tions, established protocols for both treatment procedures and 
data collection should be observed to improve the effect of 
meta-analyses and review articles.43

Conclusion
The efficacy of HRVB as an adjunctive therapy in patients 
with chronic conditions is highlighted in this comprehensive 
review. Because of the wide range of individuals and results, 
it’s hard to draw mechanical generalizations about how 
HRVB affects intervention effects. HRVB may have a regula-
tory influence on autonomic heart control by enhancing 
HRV and recovering vagal functionality, according to our 
findings. The enhanced vagal flow may therefore impact 
brain activities and improve emotional self-regulation, 
implying that HRVB could be useful as a supplemental 
remedy for various of chronic conditions. Considering the 
excellent benefits of HRVB on psychophysiological results 
across a variety of patient characteristics, it’s apparent that 
HRVB has a bright future in the treatment of chronic disor-
ders. Confirming these findings, clarifying the understanding 
of the HRV power spectrum, and determining the most effec-
tive strategy in chronic disease management will require 
more research.

Conflict of Interest
None. 

References
1. Lehrer P, Kaur K, Sharma A, Shah K, Huseby R, Bhavsar J, et al. Heart 

rate variability biofeedback improves emotional and physical health 
and performance: A systematic review and meta analysis. Applied 
Psychophysiology and Biofeedback. 2020;45(3):109–29.

2. Reneau M. Heart rate variability biofeedback to treat fibromyalgia: an 
integrative literature review. Pain Management Nursing. 2020;21(3):225–32.

3. Economides M, Lehrer P, Ranta K, Nazander A, Hilgert O, Raevuori A, 
et al. Feasibility and efficacy of the addition of heart rate variability 
biofeedback to a remote digital health intervention for depression. Applied 
Psychophysiology and Biofeedback. 2020;45(2):75–86.

4. Pizzoli SF, Marzorati C, Gatti D, Monzani D, Mazzocco K,  
Pravettoni G. A meta-analysis on heart rate variability  



309J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

S.M. Al-Tamimi
Original

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review

biofeedback and depressive symptoms. Scientific Reports. 2021; 
11(1):1–10.

5. Prinsloo GE, Rauch HL, Derman WE. A brief review and clinical application 
of heart rate variability biofeedback in sports, exercise, and rehabilitation 
medicine. The Physician and Sportsmedicine. 2014;42(2):88–99.

6. Burch JB, Ginsberg J, McLain AC, Franco R, Stokes S, Susko K, et al. Symptom 
management among cancer survivors: Randomized pilot intervention 
trial of heart rate variability biofeedback. Applied Psychophysiology and 
Biofeedback. 2020;45(2):99–108.

7. Park SM, Jung HY. Respiratory sinus arrhythmia biofeedback alters heart 
rate variability and default mode network connectivity in major depressive 
disorder: a preliminary study. International Journal of Psychophysiology. 
2020;158:225–37.

8. Amjadian M, Bahrami Ehsan H, Saboni K, Vahedi S, Rostami R, Roshani D. 
A pilot randomized controlled trial to assess the effect of Islamic spiritual 
intervention and of breathing technique with heart rate variability feedback 
on anxiety, depression and psycho-physiologic coherence in patients after 
coronary artery bypass surgery. Annals of General Psychiatry. 2020;19(1):1–10.

9. Dell’Acqua C, Dal Bò E, Benvenuti SM, Palomba D. Reduced heart rate 
variability is associated with vulnerability to depression. Journal of Affective 
Disorders Reports. 2020;1:100006.

10. Wang S-Z, Li S, Xu X-Y, Lin G-P, Shao L, Zhao Y, et al. Effect of slow 
abdominal breathing combined with biofeedback on blood pressure and 
heart rate variability in prehypertension. The Journal of Alternative and 
Complementary Medicine. 2010;16(10):1039–45.

11. Hasuo H, Kanbara K, Fukunaga M. Effect of heart rate variability biofeedback 
sessions with resonant frequency breathing on sleep: a pilot study among 
family caregivers of patients with cancer. Frontiers in Medicine. 2020;7:61.

12. Pagaduan JC, Chen Y-S, Fell JW, Wu SSX. Can heart rate variability 
biofeedback improve athletic performance? A systematic review. Journal of 
Human Kinetics. 2020;73:103.

13. Lin I-M, Lin P-Y, Fan S-Y. The Effects of Heart Rate Variability (HRV) 
Biofeedback on HRV Reactivity and Recovery During and After Anger Recall 
Task for Patients with Coronary Artery Disease. Applied Psychophysiology 
and Biofeedback. 2022:1–12.

14. Pinna T, Edwards DJ. A systematic review of associations between 
interoception, vagal tone, and emotional regulation: Potential applications 
for mental health, wellbeing, psychological flexibility, and chronic 
conditions. Frontiers in Psychology. 2020;11:1792.

15. Reneau M. Feasibility and acceptability of heart rate variability biofeedback 
in a group of Veterans with fibromyalgia. The Journal of Alternative and 
Complementary Medicine. 2020;26(11):1025–31.

16. Karavidas MK, Lehrer PM, Vaschillo E, Vaschillo B, Marin H, Buyske 
S, et al. Preliminary results of an open label study of heart rate 
variability biofeedback for the treatment of major depression. Applied 
Psychophysiology and Biofeedback. 2007;32(1):19–30.

17. Schuman DL, Killian MO. Pilot study of a single session heart rate variability 
biofeedback intervention on veterans’ posttraumatic stress symptoms. 
Applied Psychophysiology and Biofeedback. 2019;44(1):9–20.

18. Climov D, Lysy C, Berteau S, Dutrannois J, Dereppe H, Brohet C,  
et al. Biofeedback on heart rate variability in cardiac rehabilitation: 
practical feasibility and psycho-physiological effects. Acta Cardiologica. 
2014;69(3):299–307.

19. de Bruin EI, Van der Zwan J, Bögels SM. A RCT comparing daily mindfulness 
meditations, biofeedback exercises, and daily physical exercise on attention 
control, executive functioning, mindful awareness, self-compassion, and 
worrying in stressed young adults. Mindfulness. 2016;7(5):1182–92.

20. Tan G, Dao TK, Farmer L, Sutherland RJ, Gevirtz R. Heart rate variability 
(HRV) and posttraumatic stress disorder (PTSD): a pilot study. Applied 
Psychophysiology and Biofeedback. 2011;36(1):27–35.

21. Greenberg BR, Grossman EF, Bolwell G, Reynard AK, Pennell NA, Moravec 
CS, et al. Biofeedback assisted stress management in patients with lung 
cancer: a feasibility study. Applied Psychophysiology and Biofeedback. 
2015;40(3):201–8.

22. Jester DJ, Rozek EK, McKelley RA. Heart rate variability biofeedback: 
implications for cognitive and psychiatric effects in older adults. Aging & 
Mental Health. 2019;23(5):574–80.

23. Trousselard M, Canini F, Claverie D, Cungi C, Putois B, Franck N. Cardiac 
coherence training to reduce anxiety in remitted schizophrenia, a pilot 
study. Applied Psychophysiology and Biofeedback. 2016;41(1):61–9.

24. Chang W-L, Lee J-T, Li C-R, Davis AH, Yang C-C, Chen Y-J. Effects of heart rate 
variability biofeedback in patients with acute ischemic stroke: A randomized 
controlled trial. Biological Research for Nursing. 2020;22(1):34–44.

25. Nolan RP, Floras JS, Harvey PJ, Kamath MV, Picton PE, Chessex C, et al. 
Behavioral neurocardiac training in hypertension: a randomized, controlled 
trial. Hypertension. 2010;55(4):1033–9.

26. Nolan R, Floras J, Ahmed L, Harvey P, Hiscock N, Hendrickx H, et al. 
Behavioural modification of the cholinergic anti‐inflammatory response 
to C‐reactive protein in patients with hypertension. Journal of Internal 
Medicine. 2012;272(2):161–9.

27. Lehrer PM, Irvin CG, Lu S-E, Scardella A, Roehmheld-Hamm B, Aviles-Velez 
M, et al. Heart rate variability biofeedback does not substitute for asthma 
steroid controller medication. Applied Psychophysiology and Biofeedback. 
2018;43(1):57–73.

28. Hartogs BM, Bartels-Velthuis AA, Van der Ploeg K, Bos EH. Heart rate 
variability biofeedback stress relief program for depression. Methods of 
Information in Medicine. 2017;56(06):419–26.

29. Caldwell YT, Steffen PR. Adding HRV biofeedback to psychotherapy 
increases heart rate variability and improves the treatment of major 
depressive disorder. International Journal of Psychophysiology. 2018; 
131:96–101.

30. Lin I-M, Fan S-Y, Yen C-F, Yeh Y-C, Tang T-C, Huang M-F, et al. Heart rate 
variability biofeedback increased autonomic activation and improved 
symptoms of depression and insomnia among patients with major 
depression disorder. Clinical Psychopharmacology and Neuroscience. 
2019;17(2):222.

31. Dobbin A, Dobbin J, Ross S, Graham C, Ford M. Randomised controlled trial 
of brief intervention with biofeedback and hypnotherapy in patients with 
refractory irritable bowel syndrome. The Journal of the Royal College of 
Physicians of Edinburgh. 2013;43(1):15–23.

32. Van Der Zwan JE, De Vente W, Huizink AC, Bögels SM, De Bruin EI. Physical 
activity, mindfulness meditation, or heart rate variability biofeedback for 
stress reduction: a randomized controlled trial. Applied Psychophysiology 
and Biofeedback. 2015;40(4):257–68.

33. Meyer P-W, Friederich H-C, Zastrow A. Breathe to ease-Respiratory 
biofeedback to improve heart rate variability and coping with stress in 
obese patients: A pilot study. Mental Health & Prevention. 2018;11:41–6.

34. Kim S, Zemon V, Cavallo MM, Rath JF, McCraty R, Foley FW. Heart rate 
variability biofeedback, executive functioning and chronic brain injury. Brain 
Injury. 2013;27(2):209–22.

35. Hallman DM, Olsson EM, Von Schéele B, Melin L, Lyskov E. Effects of heart 
rate variability biofeedback in subjects with stress-related chronic neck pain: 
a pilot study. Applied Psychophysiology and Biofeedback. 2011;36(2):71–80.

36. Weeks DL, Whitney AA, Tindall AG, Carter GT. Pilot randomized 
trial comparing intersession scheduling of biofeedback results to 
individuals with chronic pain: Influence on psychologic function and 
pain intensity. American Journal of Physical Medicine & Rehabilitation. 
2015;94(10S):869–78.

37. Ginsberg JP, Berry ME, Powell DA. Cardiac coherence and posttraumatic 
stress disorder in combat veterans. Alternative Therapies in Health & 
Medicine. 2010;16(4).

38. McCraty R, Childre D. Coherence: bridging personal, social, and global 
health. Altern Ther Health Med. 2010;16(4):10–24.

39. Schwerdtfeger AR, Schwarz G, Pfurtscheller K, Thayer JF, Jarczok MN, 
Pfurtscheller G. Heart rate variability (HRV): From brain death to 
resonance breathing at 6 breaths per minute. Clinical Neurophysiology. 
2020;131(3):676–93.

40. Richard Gevirtz PhD B. The promise of heart rate variability biofeedback: 
Evidence-based applications. Biofeedback (Online). 2013;41(3):110.

41. Shaffer F, McCraty R. Zerr Ch.(2014) A healthy heart is not a metronome: an 
integrative review of the heart’s anatomy and heart rate variability. Frontiers 
in Psychology. 5.

42. Shaffer F, Ginsberg J. An overview of heart rate variability metrics and 
norms. Front Public Health. 2017; 5: 258. Epub 2017/10/17. https://doi. 
org/10.3389/fpubh. 2017.00258 PMID: 29034226; 2017.

43. Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal 
tone in psychophysiological research–recommendations for experiment 
planning, data analysis, and data reporting. Frontiers in Psychology. 
2017;8:213.

44. Kromenacker BW, Sanova AA, Marcus FI, Allen JJ, Lane RD. Vagal mediation 
of low-frequency heart rate variability during slow yogic breathing. 
Psychosomatic Medicine. 2018;80(6):581–7.

45. Larsen P, Tzeng Y, Sin P, Galletly D. Respiratory sinus arrhythmia in conscious 
humans during spontaneous respiration. Respiratory physiology & 
Neurobiology. 2010;174(1-2):111–8.

46. Fatisson J, Oswald V, Lalonde F. Influence diagram of physiological and 
environmental factors affecting heart rate variability: an extended literature 
overview. Heart International. 2016;11(1):heartint. 5000232.

47. Yu L-C, Lin I-M, Fan S-Y, Chien C-L, Lin T-H. One-year cardiovascular 
prognosis of the randomized, controlled, short-term heart rate variability 
biofeedback among patients with coronary artery disease. International 
Journal of Behavioral Medicine. 2018;25(3):271–82.

https://doi


310 J Contemp Med Sci | Vol. 8, No. 5, September-October 2022: 295–310

Biofeedback of Heart Rate Variability in the Treatment of Chronic Diseases: A Systematic Review
Original

S.M. Al-Tamimi

48. Feldman JM, Matte L, Interian A, Lehrer PM, Lu S-E, Scheckner B, et al. 
Psychological treatment of comorbid asthma and panic disorder in Latino 
adults: Results from a randomized controlled trial. Behaviour Research and 
Therapy. 2016;87:142–54.

49. Lin I-M, Ko J-M, Fan S-Y, Yen C-F. Heart rate variability and the efficacy 
of biofeedback in heroin users with depressive symptoms. Clinical 
Psychopharmacology and Neuroscience. 2016;14(2):168.

50. Lehrer P, Vaschillo B, Zucker T, Graves J, Katsamanis M, Aviles M, et al. 
Protocol for heart rate variability biofeedback training. Biofeedback. 
2013;41(3).

51. Szulczewski MT. An anti-hyperventilation instruction decreases the drop in 
end-tidal CO2 and symptoms of hyperventilation during breathing at 0.1 
Hz. Applied Psychophysiology and Biofeedback. 2019;44(3):247–56.

52. Modesti PA, Ferrari A, Bazzini C, Boddi M. Time sequence of autonomic 
changes induced by daily slow-breathing sessions. Clinical Autonomic 
Research. 2015;25(2):95–104.

53. Lin I-M, Tai L, Fan S-Y. Breathing at a rate of 5.5 breaths per minute with 
equal inhalation-to-exhalation ratio increases heart rate variability. 
International Journal of Psychophysiology. 2014;91(3):206–11.

54. Wheat AL, Larkin KT. Biofeedback of heart rate variability and related 
physiology: A critical review. Applied Psychophysiology and Biofeedback. 
2010;35(3):229–42.

55. Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability 
biofeedback training on stress and anxiety: a meta-analysis. Psychological 
Medicine. 2017;47(15):2578–86.

56. Patron E, Messerotti Benvenuti S, Favretto G, Valfre C, Bonfa C, Gasparotto 
R, et al. Biofeedback assisted control of respiratory sinus arrhythmia as a 
biobehavioral intervention for depressive symptoms in patients after cardiac 
surgery: a preliminary study. Applied Psychophysiology and Biofeedback. 
2013;38(1):1–9.

57. Tatschl JM, Hochfellner SM, Schwerdtfeger AR. Implementing mobile 
HRV biofeedback as adjunctive therapy during inpatient psychiatric 
rehabilitation facilitates recovery of depressive symptoms and enhances 
autonomic functioning short-term: A 1-year pre–post-intervention follow-
up pilot study. Frontiers in Neuroscience. 2020;14:738.

58. Wu JK, Huang Z, Zhang Z, Xiao W, Jiang H. Quantitative assessment 
of autonomic regulation of the cardiac system. Journal of Healthcare 
Engineering. 2019;2019.

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative 
works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

https://doi.org/10.22317/jcms.v8i5.1289